Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmather Holdings Ltd
C.PHRM
Alternate Symbol(s):
PHRRF
psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The...
Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:24pm
@ the Bell: Tech drop takes a bite out of the TSX
Technology shares led the decliners as the sector endured its worst day in more than a month on the TSX, dragged down by crypto miners.
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:58am
Buzz on the Bullboards: A recap of recent activity and stocks in focus
After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.
read article.
New PEA Indicates an Ultra Low-Cost Uranium Project with Huge Exploration Upside
posted Apr 26, 2024 9:00am by
Blue Sky Uranium Corp
-
|
This PEA reaffirms that the deposit is a leading low-cost uranium-vanadium project. We believe that this resurgent uranium market has a strong long-term outlook and we are therefore preparing to complete a prefeasibility study as soon as possible ...read more
(442)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Comment by
TheLandedEagles
on Apr 24, 2024 11:00am
RE:RE:Why low-cost ketamine is still inaccessible to many...
For sure...thats how I see things here for PHRM. Short and long term, this company will be huge in valuation. Time will only tell of coarse. Thats why I'm in and accumulating a very large position
...more
(10)
•••
BradlTheGerman
X
View Profile
View Bullboard History
Comment by
BradlTheGerman
on Apr 24, 2024 4:17am
RE:Why low-cost ketamine is still inaccessible to many...
The article describes very well that ketamine can help in many areas of medicine, but that this fails due to regulations, among other things. If the FDA grants approval, which I assume it
...more
(10)
•••
BradlTheGerman
X
View Profile
View Bullboard History
Post by
BradlTheGerman
on Apr 24, 2024 4:11am
Why low-cost ketamine is still inaccessible to many...
Why low-cost ketamine is still inaccessible to many with severe depression A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for
...more
(442)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Comment by
TheLandedEagles
on Apr 23, 2024 2:46pm
RE:RE:Only Up From Here!!!...FDA approval round the Corner!!!
Well...only God knows!!!...I dont give price predictions. Do know, in my opinion...PHRM, is drastically under valued today with its market valuation and with the anticipated near term probable FDA
...more
(28)
•••
Sailormark
X
View Profile
View Bullboard History
Comment by
Sailormark
on Apr 22, 2024 8:45pm
RE:Only Up From Here!!!...FDA approval round the Corner!!!
How high will it go?
(442)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Post by
TheLandedEagles
on Apr 22, 2024 4:39pm
Only Up From Here!!!...FDA approval round the Corner!!!
Shortly we hear of FDA APPROVAL,..and suspect other great news announced of partnership with PHARMA's. This company at this point has been de-risked, and highly probable of approval of
...more
(442)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Post by
TheLandedEagles
on Apr 19, 2024 11:09am
Closer Today to APPROVAL..!!!.Big Question, HOW HIGH..
HOW HIGH DO WE GO ON FDA APPROVAL??...FDA approval is a reality and just around the corner. This company is worth a hell of a lot more than today..PHRM, has a extremely low share count..only
...more
(28)
•••
Sailormark
X
View Profile
View Bullboard History
Comment by
Sailormark
on Apr 18, 2024 10:33pm
RE:Delayed
Yes. And when FDA approved I think $1-2-3-4 plus will come quickly.
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Post by
Itistoo
on Apr 18, 2024 5:48pm
Delayed
Theres the delay im sure most of us were expecting with the wording and deficiencies. Good news is that their are no further deficiencies, im sure a new goal date will come soon, hopefully not to far
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 18, 2024 4:00pm
New Press Release - PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced receipt of a Complete Response Letter (“CRL”) for its Priority Original Abbreviated New Drug Application (“ANDA...
read article.
(1)
•••
Glloyd
X
View Profile
View Bullboard History
Post by
Glloyd
on Apr 17, 2024 3:25pm
It’s sure taking its time!
With only 11 days left before @possibly FDA , I think the stock would at least rise another $.20-$.25 before FDA So I would think next week you@ll see increases every day I would hope I'll
...more
(1)
•••
Glloyd
X
View Profile
View Bullboard History
Post by
Glloyd
on Apr 17, 2024 1:38pm
It’s sure taking its time!
With only 11 days left before possibly FDA , I think the stock would at least rise another $.20-$.25 before FDA So I would think next week you'll see increases every day I would hope I guess
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 16, 2024 8:00am
New Press Release - PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated New Drug Application (“ANDA”) for Ketamine that was accepted by the U.S...
read article.
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Apr 13, 2024 3:15pm
RE:Bigger exchange
FDA is just the first step, obviously a very necessary one. Company still has to execute sales, partnerships etc. Nasdaq wouldnt make sense untill they can start realizing income from their product
...more
(28)
•••
Sailormark
X
View Profile
View Bullboard History
Post by
Sailormark
on Apr 13, 2024 12:27pm
Bigger exchange
With FDA approval with this stock move to a bigger exchange.? NASDAQ?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil